Skip to content
Screener

Kiniksa Pharmaceuticals International, plc KNSA Operating margin

Operating margin at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
32.6%+24.0pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-333.5%-114pp
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
48.4%+28.4pp
Cytokinetics logo
CytokineticsCYTK
-1,046.1%+1,858pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-466.8%-173pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-90.5%-41.2pp

Other financials

Income statement

See full
Revenue$243.6M+55.4%
Gross profit$220.0M+59.2%
Operating income$27.2M+34.9%
Net income$25.4M+42.6%
EPS (diluted)$0.30+30.4%

Balance sheet

See full
Cash & equivalents$175.7M-8.5%
Total debt$8.9M-8.9%
Total equity$654.1M+32.1%
Total assets$896.1M+35.5%

Cash flow

See full
Operating cash flow$47.2M+68.0%
CapEx$663.0K+302%
Free cash flow$46.5M+66.6%

Valuation

See full
Market cap$5.97B+146%
Enterprise value$5.8B+159%
P/E74×-432×
P/S7.1×+2.5×

Profitability

See full
Gross margin89.8%+3.9pp
Net margin9.6%+8.7pp
FCF margin21.7%+8.8pp

Returns & leverage

See full
Return on equity14%+13.0pp
Debt / equity0×0.0×
Current ratio3.9×+0.3×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

operating income/total revenue=11.9%

Based on trailing twelve months.

The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →

Filed
Jul 28, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087545

FAQ

What is Kiniksa Pharmaceuticals International, plc's operating margin?
Kiniksa Pharmaceuticals International, plc (KNSA) reported operating margin of 11.9% in Q2 2026.
How has Kiniksa Pharmaceuticals International, plc's operating margin changed year-over-year?
Kiniksa Pharmaceuticals International, plc's operating margin increased by 1310.3% year-over-year, from 0.8% to 11.9%.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's operating margin?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's operating margin has grown at a -59.1% compound annual growth rate (CAGR), from -406.4% to 11.4%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Kiniksa Pharmaceuticals International, plc's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude